Innovent Biologics, Inc. (IVBXF)
10.65
-0.90
(-7.78%)
USD |
OTCM |
Oct 26, 16:00
Innovent Biologics Price : 10.65 for Oct. 26, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 26, 2026 | 11.50 | 11.50 | 10.65 | 10.65 | 1620.00 |
| Oct 23, 2026 | 11.55 | 11.55 | 11.55 | 11.55 | 819.00 |
| Oct 22, 2026 | 11.60 | 11.60 | 11.60 | 11.60 | 1131.00 |
| Oct 21, 2026 | 12.21 | 12.21 | 12.21 | 12.21 | 727.00 |
| Oct 20, 2026 | 12.01 | 12.01 | 12.01 | 12.01 | 589.00 |
| Oct 19, 2026 | 12.20 | 12.20 | 12.05 | 12.20 | 14925.00 |
| Oct 16, 2026 | 12.50 | 12.50 | 12.50 | 12.50 | 590.00 |
| Oct 15, 2026 | 12.56 | 12.56 | 12.50 | 12.50 | 1305.00 |
| Oct 14, 2026 | 11.37 | 11.37 | 11.37 | 11.37 | 1304.00 |
| Oct 13, 2026 | 10.82 | 11.64 | 10.82 | 11.35 | 14255.00 |
| Oct 12, 2026 | 12.46 | 12.46 | 10.31 | 10.31 | 2356.00 |
| Oct 09, 2026 | 12.14 | 12.14 | 12.14 | 12.14 | 3256.00 |
| Oct 08, 2026 | 12.00 | 12.00 | 12.00 | 12.00 | 183.00 |
| Oct 07, 2026 | 12.80 | 12.80 | 12.80 | 12.80 | 1208.00 |
| Oct 06, 2026 | 12.20 | 12.20 | 12.20 | 12.20 | 413.00 |
| Oct 05, 2026 | 12.20 | 12.20 | 12.20 | 12.20 | 5701.00 |
| Oct 02, 2026 | 12.80 | 12.80 | 12.80 | 12.80 | 396.00 |
| Oct 01, 2026 | 12.40 | 12.51 | 12.40 | 12.51 | 5703.00 |
| Sep 30, 2026 | 12.53 | 12.53 | 12.53 | 12.53 | 735.00 |
| Sep 29, 2026 | 13.36 | 13.36 | 13.36 | 13.36 | 601.00 |
| Sep 28, 2026 | 13.36 | 13.36 | 13.36 | 13.36 | 428.00 |
| Sep 25, 2026 | 12.45 | 12.45 | 12.45 | 12.45 | 561.00 |
| Sep 24, 2026 | 13.82 | 13.82 | 12.45 | 12.45 | 1411.00 |
| Sep 23, 2026 | 12.55 | 12.55 | 12.55 | 12.55 | 479.00 |
| Sep 22, 2026 | 14.25 | 14.25 | 14.25 | 14.25 | 1158.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Ascletis Pharma, Inc. | 0.73 |
| CStone Pharmaceuticals Co. Ltd. | 0.7547 |
| RemeGen Co., Ltd. | 9.96 |
| InnoCare Pharma Ltd. | 1.60 |
| Adagene, Inc. | 2.58 |
Price Related Metrics
| PE Ratio | 106.82 |
| PS Ratio | 8.365 |
| Price to Free Cash Flow | 10.27 |
| Earnings Yield | 0.94% |
| Market Cap | 18.51B |
| Operating PE Ratio | 49.52 |
| Normalized PE Ratio | 121.30 |